Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer
Clinical trial NCT02579811 · COMPLETED
Trial details
- NCT number
- NCT02579811
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2019-08-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.